Tsu, Japan

Keisuke Fujii

This inventor holds 1 USPTO granted patent. Top assignee: Mie University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keisuke Fujii. Retrieved from https://idiyas.com/inventor/keisuke-fujii-s8yyjpri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Keisuke Fujii: Innovator in T-Cell Receptor Technology

Introduction

Keisuke Fujii is a prominent inventor based in Tsu-shi, Mie, Japan. He has made significant contributions to the field of immunology, particularly in the development of T-cell receptor technology. His innovative work has garnered attention in both academic and research circles.

Latest Patents

Keisuke Fujii holds a patent for a T-cell receptor, which represents a crucial advancement in the understanding and manipulation of immune responses. This patent highlights his commitment to enhancing therapeutic strategies in immunology. He has 1 patent to his name, showcasing his innovative contributions to the field.

Career Highlights

Fujii is affiliated with Mie University, where he continues to engage in groundbreaking research. His academic background and ongoing projects reflect his dedication to advancing scientific knowledge and improving health outcomes through innovative technologies.

Collaborations

Throughout his career, Keisuke Fujii has collaborated with esteemed colleagues, including Hiroshi Shiku and Yoshihiro Miyahara. These partnerships have fostered a collaborative environment that enhances research and development in their respective fields.

Conclusion

Keisuke Fujii's work in T-cell receptor technology exemplifies the impact of innovative thinking in the realm of immunology. His contributions not only advance scientific understanding but also pave the way for future developments in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…